{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:27:05Z","timestamp":1787027225848,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangxi Zhuang Autonomous Region Health and Family Planning Commission self-funded scientific research project","award":["Z-B20231462"],"award-info":[{"award-number":["Z-B20231462"]}]},{"name":"Youth fund of Guangxi natural science foundation projects","award":["2018GXNSFBA281113"],"award-info":[{"award-number":["2018GXNSFBA281113"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-026-02399-2","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:24:07Z","timestamp":1780910647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The miR-4512\/PDZK1IP1 axis in hepatocellular carcinoma: clinical significance, diagnostic value, and functional validation"],"prefix":"10.1186","volume":"19","author":[{"given":"Xiang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihang","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"1","key":"2399_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00441-011-1246-y","volume":"347","author":"S Dooley","year":"2012","unstructured":"Dooley S, Ten Dijke P. TGF-\u03b2 in progression of liver disease. Cell Tissue Res. 2012;347(1):245\u201356.","journal-title":"Cell Tissue Res"},{"issue":"5","key":"2399_CR2","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","volume":"127","author":"G Fattovich","year":"2004","unstructured":"Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127(5):S35\u201350.","journal-title":"Gastroenterology"},{"issue":"33","key":"2399_CR3","doi-asserted-by":"publisher","first-page":"5093","DOI":"10.1038\/sj.onc.1206557","volume":"22","author":"TM Block","year":"2003","unstructured":"Block TM, Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene. 2003;22(33):5093\u2013107.","journal-title":"Oncogene"},{"issue":"6","key":"2399_CR4","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","volume":"154","author":"K Tzartzeva","year":"2018","unstructured":"Tzartzeva K, Obi J, Rich NE, Parikh ND, Marrero JA, Yopp A, et al. Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis. Gastroenterology. 2018;154(6):1706\u201318. e1.","journal-title":"Gastroenterology"},{"key":"2399_CR5","doi-asserted-by":"crossref","unstructured":"Balogh J, Victor D III, Asham EH, Burroughs SG, Boktour M, Saharia A et al. Hepatocellular carcinoma: a review. J hepatocellular carcinoma. 2016;3:41\u201353.","DOI":"10.2147\/JHC.S61146"},{"key":"2399_CR6","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.bpg.2014.08.007","volume":"ClinGastroenter","author":"C Bosetti","year":"2014","unstructured":"Bosetti C, Turati F, La Vecchia C. Hepatocellular carcinoma epidemiology. Best Pract Res. 2014;ClinGastroenterol28:753\u201370.","journal-title":"Best Pract Res"},{"issue":"1","key":"2399_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","volume":"137","author":"JA Marrero","year":"2009","unstructured":"Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, et al. \u03b1-fetoprotein, des-\u03b3 carboxyprothrombin, and lectin-bound \u03b1-fetoprotein in early hepatocellular carcinoma. Gastroenterology. 2009;137(1):110\u20138.","journal-title":"Gastroenterology"},{"issue":"1","key":"2399_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2174\/0113892029308243240709073945","volume":"26","author":"IP Gudivada","year":"2025","unstructured":"Gudivada IP, Amajala KC. Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment. Curr Genom. 2025;26(1):48\u201380. https:\/\/doi.org\/10.2174\/0113892029308243240709073945.","journal-title":"Curr Genom"},{"key":"2399_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ncrna.2025.11.002","volume":"16","author":"A Jabri","year":"2026","unstructured":"Jabri A, Mhannayeh A, Alsharif M, Taftafa B, Mujtaba T, Akbar A, et al. Integrative analysis of tissue and circulating miRNAs as biomarkers for progression and survival in hepatocellular carcinoma. Non-coding RNA Res. 2026;16:167\u201377.","journal-title":"Non-coding RNA Res"},{"key":"2399_CR10","doi-asserted-by":"publisher","first-page":"e18761429358008","DOI":"10.2174\/0118761429358008250305070518","volume":"17","author":"W Xu","year":"2024","unstructured":"Xu W, Liao S, Hu Y, Huang Y, Zhou J. Upregulation of miR-3130-5p Enhances Hepatocellular Carcinoma Growth by Suppressing Ferredoxin 1: miR-3130-5p Enhances HCC Growth via Inhibiting FDX1. Curr Mol Pharmacol. 2024;17:e18761429358008. https:\/\/doi.org\/10.2174\/0118761429358008250305070518.","journal-title":"Curr Mol Pharmacol"},{"issue":"19Supplement","key":"2399_CR11","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1158\/1538-7445.AM2014-4387","volume":"74","author":"CW Lee","year":"2014","unstructured":"Lee CW, Kang MR, Yun J, Oh SJ, Kang JS. Up-regulation of VHL by miR-1273\u00a0C inhibits renal cell carcinoma. Cancer Res. 2014;74(19Supplement):4387.","journal-title":"Cancer Res"},{"issue":"23","key":"2399_CR12","doi-asserted-by":"publisher","first-page":"6438","DOI":"10.1158\/1078-0432.CCR-12-3186","volume":"19","author":"T Iwaya","year":"2013","unstructured":"Iwaya T, Fukagawa T, Suzuki Y, Takahashi Y, Sawada G, Ishibashi M, et al. Contrasting expression patterns of histone mRNA and microRNA 760 in patients with gastric cancer. Clin Cancer Res. 2013;19(23):6438\u201349.","journal-title":"Clin Cancer Res"},{"key":"2399_CR13","doi-asserted-by":"publisher","first-page":"101986","DOI":"10.1016\/j.mcp.2024.101986","volume":"78","author":"BM Hussen","year":"2024","unstructured":"Hussen BM, Rasul MF, Faraj GSH, Abdullah SR, Sulaiman SH, Pourmoshtagh H, et al. Role of microRNAs in neutrophil extracellular trap formation and prevention: Systematic narrative review. Mol Cell Probes. 2024;78:101986.","journal-title":"Mol Cell Probes"},{"key":"2399_CR14","doi-asserted-by":"publisher","first-page":"756825","DOI":"10.3389\/fimmu.2021.756825","volume":"12","author":"B Yang","year":"2021","unstructured":"Yang B, Huang X, Xu S, Li L, Wu W, Dai Y, et al. Decreased miR-4512 levels in monocytes and macrophages of individuals with systemic lupus erythematosus contribute to innate immune activation and neutrsophil NETosis by targeting TLR4 and CXCL2. Front Immunol. 2021;12:756825.","journal-title":"Front Immunol"},{"key":"2399_CR15","doi-asserted-by":"publisher","first-page":"177156","DOI":"10.1016\/j.ejphar.2024.177156","volume":"986","author":"H Xu","year":"2025","unstructured":"Xu H, Su J, Chen X, Li J, Li Z, Zheng N, et al. Identification of hsa_circ_0076957 and miR-4512-targeted COL19A1 as regulators in clopidogrel resistance among stable coronary heart disease patients through comprehensive circRNA and miRNA analysis. Eur J Pharmacol. 2025;986:177156.","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"2399_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.14348\/molcells.2023.2174","volume":"46","author":"MJ Park","year":"2023","unstructured":"Park MJ, Jeong E, Lee EJ, Choi HJ, Moon BH, Kang K, et al. RNA editing enzyme ADAR1 suppresses the mobility of cancer cells via ARPIN. Mol Cells. 2023;46(6):351\u20139.","journal-title":"Mol Cells"},{"key":"2399_CR17","doi-asserted-by":"publisher","first-page":"e18761429310703","DOI":"10.2174\/0118761429310703240823045808","volume":"17","author":"B Sensi","year":"2024","unstructured":"Sensi B, Angelico R, Toti L, Conte L, Coppola A, Tisone G, et al. Mechanism, Potential, and Concerns of Immunotherapy for Hepatocellular Carcinoma and Liver Transplantation. Curr Mol Pharmacol. 2024;17:e18761429310703. https:\/\/doi.org\/10.2174\/0118761429310703240823045808.","journal-title":"Curr Mol Pharmacol"},{"issue":"1","key":"2399_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/0113892029273682240111052317","volume":"25","author":"R Mu","year":"2024","unstructured":"Mu R, Chang M, Feng C, Cui Y, Li T, Liu C, et al. Analysis of the Expression of PRDX6 in Patients with Hepatocellular Carcinoma and its Effect on the Phenotype of Hepatocellular Carcinoma Cells. Curr Genom. 2024;25(1):2\u201311. https:\/\/doi.org\/10.2174\/0113892029273682240111052317.","journal-title":"Curr Genom"},{"issue":"1","key":"2399_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/jcb.21163","volume":"101","author":"M Guijarro","year":"2007","unstructured":"Guijarro M, Castro M, Romero L, Moneo V, Carnero A. Large scale genetic screen identifies MAP17 as protein bypassing TNF-induced growth arrest. J Cell Biochem. 2007;101(1):112\u201321.","journal-title":"J Cell Biochem"},{"issue":"6","key":"2399_CR20","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.3390\/ani13061046","volume":"13","author":"D Chen","year":"2023","unstructured":"Chen D, Li Y, Hu T, Gong C, Lu G, Ma X, et al. Pdzk1-interacting protein 1 (pdzkip1) inhibits goat subcutaneous preadipocyte differentiation through promoting autophagy. Animals. 2023;13(6):1046.","journal-title":"Animals"},{"key":"2399_CR21","doi-asserted-by":"publisher","first-page":"154091","DOI":"10.1016\/j.prp.2022.154091","volume":"238","author":"W Zhang","year":"2022","unstructured":"Zhang W, Zheng D, Jin L, Hirachan S, Bhandari A, Li Y, et al. PDZK1IP1 gene promotes proliferation, migration, and invasion in papillary thyroid carcinoma. Pathology-Research Pract. 2022;238:154091.","journal-title":"Pathology-Research Pract"},{"issue":"1","key":"2399_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12885-021-09060-4","volume":"22","author":"J Du","year":"2022","unstructured":"Du J, Gu J, Deng J, Kong L, Guo Y, Jin C, et al. The expression and survival significance of sodium glucose transporters in pancreatic cancer. BMC Cancer. 2022;22(1):116.","journal-title":"BMC Cancer"},{"issue":"8","key":"2399_CR23","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1093\/carcin\/bgm083","volume":"28","author":"MV Guijarro","year":"2007","unstructured":"Guijarro MV, Leal JF, Fominaya J, Blanco-Aparicio C, Alonso S, Lleonart M, et al. MAP17 overexpression is a common characteristic of carcinomas. Carcinogenesis. 2007;28(8):1646\u201352.","journal-title":"Carcinogenesis"},{"key":"2399_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.25259\/Cytojournal_200_2024","volume":"22","author":"K Yu","year":"2025","unstructured":"Yu K, Yu Y, Zhang C, Hao L. Mechanistic insights into PDZK1-interacting protein 1 on the malignant progression of colorectal carcinoma. CytoJournal. 2025;22:52.","journal-title":"CytoJournal"},{"issue":"54","key":"2399_CR25","doi-asserted-by":"publisher","first-page":"92589","DOI":"10.18632\/oncotarget.21506","volume":"8","author":"X Chen","year":"2017","unstructured":"Chen X, Liao Y, Yu Y, Zhu P, Li J, Qin L, et al. Elevation of MAP17 enhances the malignant behavior of cells via the Akt\/mTOR pathway in hepatocellular carcinoma. Oncotarget. 2017;8(54):92589.","journal-title":"Oncotarget"},{"issue":"1","key":"2399_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13046-021-01927-5","volume":"40","author":"F Dong","year":"2021","unstructured":"Dong F, Li R, Wang J, Zhang Y, Yao J, Jiang S-H, et al. Hypoxia-dependent expression of MAP17 coordinates the Warburg effect to tumor growth in hepatocellular carcinoma. J Experimental Clin Cancer Res. 2021;40(1):121.","journal-title":"J Experimental Clin Cancer Res"},{"issue":"10","key":"2399_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat reviews Gastroenterol Hepatol. 2019;16(10):589\u2013604.","journal-title":"Nat reviews Gastroenterol Hepatol"},{"issue":"3","key":"2399_CR28","doi-asserted-by":"publisher","first-page":"362","DOI":"10.4254\/wjh.v7.i3.362","volume":"7","author":"J Tejeda-Maldonado","year":"2015","unstructured":"Tejeda-Maldonado J, Garc\u00eda-Ju\u00e1rez I, Aguirre-Valadez J, Gonz\u00e1lez-Aguirre A, Vilatob\u00e1-Chapa M, Armengol-Alonso A, et al. Diagnosis and treatment of hepatocellular carcinoma: An update. World J Hepatol. 2015;7(3):362.","journal-title":"World J Hepatol"},{"issue":"1","key":"2399_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.14218\/JCTH.2021.00176","volume":"10","author":"A Turshudzhyan","year":"2021","unstructured":"Turshudzhyan A, Wu GY. Persistently rising alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: a review. J Clin Translational Hepatol. 2021;10(1):159.","journal-title":"J Clin Translational Hepatol"},{"issue":"10","key":"2399_CR30","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/j.1440-1746.2008.05395.x","volume":"23","author":"FA Durazo","year":"2008","unstructured":"Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, et al. Des-\u03b3\u2010carboxyprothrombin, \u03b1\u2010fetoprotein and AFP\u2010L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol. 2008;23(10):1541\u20138.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"2399_CR31","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/hep.27304","volume":"61","author":"DG Mitchell","year":"2015","unstructured":"Mitchell DG, Bruix J, Sherman M, Sirlin CB. LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI\u2010RADS Management Working Group and future directions. Hepatology. 2015;61(3):1056\u201365.","journal-title":"Hepatology"},{"issue":"10","key":"2399_CR32","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1093\/carcin\/bgm124","volume":"28","author":"MV Guijarro","year":"2007","unstructured":"Guijarro MV, Leal JF, Blanco-Aparicio C, Alonso S, Fominaya J, Lleonart M, et al. MAP17 enhances the malignant behavior of tumor cells through ROS increase. Carcinogenesis. 2007;28(10):2096\u2013104.","journal-title":"Carcinogenesis"},{"issue":"8","key":"2399_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12032-025-02873-4","volume":"42","author":"A Choudhary","year":"2025","unstructured":"Choudhary A, Kumar A, Munshi A. Genetic variants in oncogenic miRNA and 3\u2032 untranslated region of tumor suppressor genes: emerging insight into cancer genetics. Med Oncol. 2025;42(8):303.","journal-title":"Med Oncol"},{"issue":"4","key":"2399_CR34","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s11010-024-05136-4","volume":"480","author":"SH Mohamed","year":"2025","unstructured":"Mohamed SH, Kamal MM, Reda AM, Mesbah NM, Abo-Elmatty DM, Abdel-Hamed AR. MicroRNA-205-5p inhibits the growth and migration of breast cancer through targeting Wnt\/\u03b2-catenin co-receptor LRP6 and interacting with lncRNAs. Mol Cell Biochem. 2025;480(4):2117\u201329.","journal-title":"Mol Cell Biochem"},{"key":"2399_CR35","doi-asserted-by":"crossref","unstructured":"Yang L, Dang W, Kong F, Zhang X, Zheng L, Jia L et al. miR-145-5p inhibits HER2-Positive breast cancer cells via targeting ARF6. Int J Gen Med. 2025;18:1181\u201392.","DOI":"10.2147\/IJGM.S510358"},{"issue":"1","key":"2399_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13062-024-00553-3","volume":"19","author":"FA Khan","year":"2024","unstructured":"Khan FA, Fouad D, Ataya FS, Fang N, Dong J, Ji S. FXR1 associates with and degrades PDZK1IP1 and ATOH8 mRNAs and promotes esophageal cancer progression. Biol Direct. 2024;19(1):104.","journal-title":"Biol Direct"},{"key":"2399_CR37","doi-asserted-by":"publisher","first-page":"e240342","DOI":"10.20945\/2359-4292-2024-0342","volume":"69","author":"Z-H Tian","year":"2025","unstructured":"Tian Z-H, Huang R, Li G-Q, Zhu Y-X. MAP17 contributes to the tumorigenesis of papillary thyroid carcinoma by activating the AKT signaling pathway. Archives Endocrinol Metabolism. 2025;69:e240342.","journal-title":"Archives Endocrinol Metabolism"},{"issue":"6","key":"2399_CR38","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.3892\/mmr.2016.5110","volume":"13","author":"G Yang","year":"2016","unstructured":"Yang G, Zong H. Overexpression of PDZK1IP1, EEF1A2 and RPL41 genes in intrahepatic cholangiocarcinoma. Mol Med Rep. 2016;13(6):4786\u201390.","journal-title":"Mol Med Rep"},{"issue":"68","key":"2399_CR39","doi-asserted-by":"publisher","first-page":"32958","DOI":"10.18632\/oncotarget.26010","volume":"9","author":"M Rivero","year":"2018","unstructured":"Rivero M, Peinado-Serrano J, Mu\u00f1oz-Galvan S, Espinosa-S\u00e1nchez A, Suarez-Martinez E, Felipe-Abrio B, et al. MAP17 (PDZK1IP1) and pH2AX are potential predictive biomarkers for rectal cancer treatment efficacy. Oncotarget. 2018;9(68):32958.","journal-title":"Oncotarget"},{"issue":"15","key":"2399_CR40","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1038\/sj.onc.1210279","volume":"26","author":"S Hussain","year":"2007","unstructured":"Hussain S, Schwank J, Staib F, Wang X, Harris C. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene. 2007;26(15):2166\u201376.","journal-title":"Oncogene"},{"issue":"10","key":"2399_CR41","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.celrep.2015.02.027","volume":"10","author":"J Fitamant","year":"2015","unstructured":"Fitamant J, Kottakis F, Benhamouche S, Tian HS, Chuvin N, Parachoniak CA, et al. YAP inhibition restores hepatocyte differentiation in advanced HCC, leading to tumor regression. Cell Rep. 2015;10(10):1692\u2013707.","journal-title":"Cell Rep"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-026-02399-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02399-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02399-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:28:28Z","timestamp":1787023708000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-026-02399-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2399"],"URL":"https:\/\/doi.org\/10.1186\/s12920-026-02399-2","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Approval was granted by the Ethics Committee of The Fourth Affiliated Hospital of Guangxi Medical University. Written informed consent to participate has been obtained from all the participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"132"}}